FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952454142> ?p ?o ?g. }

• W2952454142 abstract "Mast cells (MCs) are present in the painful degenerate human intervertebral disc (IVD) and are associated with disease pathogenesis. MCs release granules containing enzymatic and inflammatory factors in response to stimulants or allergens. The serine protease, tryptase, is unique to MCs and its activation of the G-protein coupled receptor, Protease Activated Receptor 2 (PAR2), induces inflammation and degradation in osteoarthritic cartilage. Our previously published work has demonstrated increased levels of MC marker tryptase in IVD samples from discogenic back pain patients compared to healthy control IVD samples including expression of chemotactic agents that may facilitate MC migration into the IVD. To further elucidate MCs' role in the IVD and mechanisms underlying its effects, we investigated whether (1) human IVD cells can promote MC migration, (2) MC tryptase can mediate up-regulation of inflammatory/catabolic process in human IVD cells and tissue, and (3) the potential of PAR2 antagonist to function as a therapeutic drug in in vitro human and ex vivo bovine pilot models of disease. MC migration was quantitatively assessed using conditioned media from primary human IVD cells and MC migration examined through Matrigel. Exposure to soluble IVD factors significantly enhanced MC migration, suggesting IVD cells can recruit MCs. We also demonstrated significant upregulation of MC chemokine SCF and angiogenic factor VEGFA gene expression in human IVD cells in vitro in response to recombinant human tryptase, suggesting tryptase can enhance recruitment of MCs and promotion of angiogenesis into the usually avascular IVD. Furthermore, tryptase can degrade proteoglycans in IVD tissue as demonstrated by significant increases in glycosaminoglycans released into surrounding media. This can create a catabolic microenvironment compromising structural integrity and facilitating vascular migration usually inhibited by the anti-angiogenic IVD matrix. Finally, as a proof of concept study, we examined the therapeutic potential of PAR2 antagonist (PAR2A) on human IVD cells and bovine organ culture IVD model. While preliminary data shows promise and points toward structural restoration of the bovine IVD including down-regulation of VEGFA, effects of PAR2 antagonist on human IVD cells differ between gender and donors suggesting that further validation is required with larger cohorts of human specimens." @default.
• W2952454142 created "2019-06-27" @default.
• W2952454142 creator A5002246073 @default.
• W2952454142 creator A5011242557 @default.
• W2952454142 creator A5020528316 @default.
• W2952454142 creator A5021287819 @default.
• W2952454142 creator A5030698818 @default.
• W2952454142 creator A5041975324 @default.
• W2952454142 creator A5061729508 @default.
• W2952454142 creator A5064896047 @default.
• W2952454142 creator A5068501813 @default.
• W2952454142 creator A5070640679 @default.
• W2952454142 date "2019-07-05" @default.
• W2952454142 modified "2023-10-18" @default.
• W2952454142 title "Mast Cell/Proteinase Activated Receptor 2 (PAR2) Mediated Interactions in the Pathogenesis of Discogenic Back Pain" @default.
• W2952454142 cites W1505597474 @default.
• W2952454142 cites W1531539296 @default.
• W2952454142 cites W1559947911 @default.
• W2952454142 cites W1599631170 @default.
• W2952454142 cites W1645519732 @default.
• W2952454142 cites W1927061739 @default.
• W2952454142 cites W1951686243 @default.
• W2952454142 cites W1965468265 @default.
• W2952454142 cites W1966120864 @default.
• W2952454142 cites W1977849332 @default.
• W2952454142 cites W1990712486 @default.
• W2952454142 cites W1991896591 @default.
• W2952454142 cites W1995063959 @default.
• W2952454142 cites W2001538429 @default.
• W2952454142 cites W2003706881 @default.
• W2952454142 cites W2012808248 @default.
• W2952454142 cites W2014566875 @default.
• W2952454142 cites W2015141049 @default.
• W2952454142 cites W2015536184 @default.
• W2952454142 cites W2015869069 @default.
• W2952454142 cites W2018174825 @default.
• W2952454142 cites W2030604088 @default.
• W2952454142 cites W2036505487 @default.
• W2952454142 cites W2036611467 @default.
• W2952454142 cites W2037583192 @default.
• W2952454142 cites W2038511363 @default.
• W2952454142 cites W2042774958 @default.
• W2952454142 cites W2043804545 @default.
• W2952454142 cites W204846031 @default.
• W2952454142 cites W2058362959 @default.
• W2952454142 cites W2059270078 @default.
• W2952454142 cites W2060302340 @default.
• W2952454142 cites W2061788070 @default.
• W2952454142 cites W2062918354 @default.
• W2952454142 cites W2068547085 @default.
• W2952454142 cites W2068747348 @default.
• W2952454142 cites W2071833026 @default.
• W2952454142 cites W2080731522 @default.
• W2952454142 cites W2085313497 @default.
• W2952454142 cites W2089332133 @default.
• W2952454142 cites W2093456571 @default.
• W2952454142 cites W2104615437 @default.
• W2952454142 cites W2106755981 @default.
• W2952454142 cites W2107277218 @default.
• W2952454142 cites W2108459765 @default.
• W2952454142 cites W2113758041 @default.
• W2952454142 cites W2116242929 @default.
• W2952454142 cites W2121787709 @default.
• W2952454142 cites W2123487526 @default.
• W2952454142 cites W2126886331 @default.
• W2952454142 cites W2128635872 @default.
• W2952454142 cites W2133543836 @default.
• W2952454142 cites W2140476594 @default.
• W2952454142 cites W2140881521 @default.
• W2952454142 cites W2148769724 @default.
• W2952454142 cites W2150271931 @default.
• W2952454142 cites W2152877642 @default.
• W2952454142 cites W2152983876 @default.
• W2952454142 cites W2186295141 @default.
• W2952454142 cites W2192080449 @default.
• W2952454142 cites W2327512308 @default.
• W2952454142 cites W2404764145 @default.
• W2952454142 cites W2504171339 @default.
• W2952454142 cites W2649656222 @default.
• W2952454142 cites W2747678233 @default.
• W2952454142 cites W2756641402 @default.
• W2952454142 cites W2762300204 @default.
• W2952454142 cites W2792716055 @default.
• W2952454142 cites W2801605155 @default.
• W2952454142 cites W2888431468 @default.
• W2952454142 cites W2940338242 @default.
• W2952454142 cites W3023062465 @default.
• W2952454142 cites W4235237347 @default.
• W2952454142 cites W4247637568 @default.
• W2952454142 doi "https://doi.org/10.3389/fncel.2019.00294" @default.
• W2952454142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6625229" @default.
• W2952454142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31333416" @default.
• W2952454142 hasPublicationYear "2019" @default.
• W2952454142 type Work @default.
• W2952454142 sameAs 2952454142 @default.
• W2952454142 citedByCount "7" @default.
• W2952454142 countsByYear W29524541422020 @default.
• W2952454142 countsByYear W29524541422021 @default.
• W2952454142 countsByYear W29524541422022 @default.
• W2952454142 countsByYear W29524541422023 @default.

• next